Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2002;33:896-900
doi: 10.1161/01.STR.0000013673.70986.AB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamada, M.
Right arrow Articles by Mizusawa, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamada, M.
Right arrow Articles by Mizusawa, H.
Related Collections
Right arrow Lipid and lipoprotein metabolism
Right arrow Risk Factors
Right arrow Genetics of Stroke
Right arrow Intracerebral Hemorrhage
Right arrow Risk Factors for Stroke

(Stroke. 2002;33:896.)
© 2002 American Heart Association, Inc.


Original Contributions

No Association of Paraoxonase Genotype or Atherosclerosis With Cerebral Amyloid Angiopathy

M. Yamada, MD, PhD; N. Sodeyama, MD, PhD; Y. Itoh, MD, PhD; E. Otomo, MD, PhD; M. Matsushita, MD, PhD H. Mizusawa, MD, PhD

From the Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan (M.Y.); Department of Neurology, Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences, Tokyo, Japan (N.S., H.M.); Departments of Internal Medicine (Y.I., E.O.) and Pathology (Y.I.), Yokufukai Geriatric Hospital, Tokyo, Japan; and Department of Neuropathology, Tokyo Institute of Psychiatry, Tokyo, Japan (M.M.).

Correspondence to Prof Masahito Yamada, Department of Neurology and Neurobiology of Aging, Kanazawa University Graduate School of Medical Science, 13-1, Takara-Machi, Kanazawa 920-8640, Japan. E-mail m-yamada{at}med.kanazawa-u.ac.jp

Background and Purpose Both cerebral amyloid angiopathy (CAA) and paraoxonase have been reported to be related to lipid metabolism and atherosclerosis. We investigated whether the paraoxonase gene (PON1) polymorphism and atherosclerosis are associated with risk of CAA.

Methods Associations of the PON1 polymorphism and atherosclerosis of the aorta and coronary and cerebral arteries with the severity of CAA were investigated in 154 elderly Japanese individuals, including 47 patients with Alzheimer’s disease.

Results The PON1 polymorphism or severity of atherosclerosis of the arteries was not associated with the severity of CAA.

Conclusions The PON1 polymorphism and atherosclerosis would not appear to be associated with risk of CAA in the elderly, although further study with larger samples is necessary for confirmation.


Key Words: Alzheimer disease • amyloid • atherosclerosis • cerebrovascular disorders • polymorphism (genetics)




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Yamada, N Sodeyama, Y Itoh, A Takahashi, E Otomo, M Matsushita, and H Mizusawa
Association of neprilysin polymorphism with cerebral amyloid angiopathy
J. Neurol. Neurosurg. Psychiatry, June 1, 2003; 74(6): 749 - 751.
[Abstract] [Full Text] [PDF]